Cargando…
COVID-19 vaccines: evidence, challenges and the future
Through an unprecedented research and development process, in early 2021, just one year after the COVID-19 pandemic started devastating the world, there are several vaccines commercially available or in advances phase of testing, each with its own characteristics and challenges. For the first time i...
Autores principales: | TANZI, ELISABETTA, GENOVESE, CAMILLA, TETTAMANZI, MATILDE, FAPPANI, CLARA, RAVIGLIONE, MARIO CARLO, AMENDOLA, ANTONELLA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore srl
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452286/ https://www.ncbi.nlm.nih.gov/pubmed/34622080 http://dx.doi.org/10.15167/2421-4248/jpmh2021.62.1S3.2084 |
Ejemplares similares
-
Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017–2022
por: Bianchi, Silvia, et al.
Publicado: (2023) -
Breakthrough Infections: A Challenge towards Measles Elimination?
por: Fappani, Clara, et al.
Publicado: (2022) -
Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy
por: Amendola, Antonella, et al.
Publicado: (2022) -
Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?
por: Canuti, Marta, et al.
Publicado: (2022) -
HPV Type-Specific Prevalence a Decade after the Implementation of the Vaccination Program: Results from a Pilot Study
por: Fappani, Clara, et al.
Publicado: (2021)